Tower Research Capital (TRC)’s Covisint Corporation COVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,812
Closed -$14K 4441
2017
Q2
$14K Sell
5,812
-18,976
-77% -$39.6K ﹤0.01% 1442
2017
Q1
$51K Buy
24,788
+3,747
+18% +$7.47K 0.01% 729
2016
Q4
$40K Buy
21,041
+11,396
+118% +$24.6K ﹤0.01% 1578
2016
Q3
$21K Sell
9,645
-195
-2% -$426 ﹤0.01% 1603
2016
Q2
$22K Buy
9,840
+7,254
+281% +$14.1K ﹤0.01% 2180
2016
Q1
$5K Sell
2,586
-2,437
-49% -$4.94K ﹤0.01% 2818
2015
Q4
$13K Buy
+5,023
New +$11.4K ﹤0.01% 1846
2015
Q1
Sell
-104
Closed 5282
2014
Q4
$0 Sell
104
-7,643
-99% -$21.9K ﹤0.01% 5161
2014
Q3
$32K Buy
7,747
+7,354
+1,871% +$33K ﹤0.01% 1935
2014
Q2
$2K Sell
393
-98
-20% -$613 ﹤0.01% 3535
2014
Q1
$4K Sell
491
-61
-11% -$614 ﹤0.01% 3520
2013
Q4
$7K Buy
+552
New +$7.02K ﹤0.01% 3347

Tower Research Capital (TRC)'s COVS Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 5,812 shares — an estimated $14K sold.

Tower Research Capital (TRC) first reported a position in COVS in Q4 2013 and held it in 12 quarters. The position peaked at $51K in Q1 2017. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,812 Covisint Corporation shares in Q3 2017, an estimated $14K.
  • Tower Research Capital (TRC) first reported a position in Covisint Corporation in Q4 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Covisint Corporation position peaked at $51K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.